Imax price target raised to $46 from $39 at Wedbush

Wedbush raised the firm’s price target on Imax (IMAX) to $46 from $39 and keeps an Outperform rating on the shares. Imax remains on Wedbush’s Best Ideas List, supported by expectations for a rising slate of filmed-for-IMAX titles, a box office increasingly fueled by both local-language and global releases, growing alternative content, and continued global footprint expansion, which position the company to exceed 50% EBITDA margins by 2028, the analyst tells investors in a research note.